Endodiag is specialized in the development of products and services aimed at improving the diagnosis of endometriosis. With its EndoGram prognosis program, the Company contributes to improving current diagnostic practice by providing additional biological information for a personalized medical and therapeutic management for each patient. In parallel, Endodiag develops a new non-invasive diagnostic test making endometriosis detection much easier and faster. Finally, the Company offers drug testing services to pharmaceutical companies enabling them to make early in-vitro evaluation of drug efficacy of cell lines and patient-derived cell cultures.
|Size (employees)||16 (est)+7%|
Endodiag total Funding
Endodiag latest funding size
Time since last funding
|4 years ago|
|Compound, Zelkova Ventures, Harmonic, Pat Condon|
Endodiag has 211 Twitter Followers. The number of followers has decreased 0.1% month over month and decreased 0.5% quarter over quarter